Holland Proton Therapy Centre (HollandPTC) has started treating patients using RayStation as the treatment planning solution, in combination with the Varian ProBeam® System and the Varian ARIA® oncology information system.
HollandPTC was the first proton therapy center established in the Netherlands. RayStation was selected over other treatment planning alternatives following an extensive tender process in 2016. RayStation received the highest assessment in several key areas, including adaptive therapy, connectivity, automation and scripting, user experience, and plan optimization. The agreement between RaySearch and HollandPTC includes both clinical and research licenses.
Johan Löf, CEO of RaySearch, says: “We are glad to see that HollandPTC has completed its first patient treatment using RayStation. Proton therapy is an important area of focus for RaySearch, and we have designed RayStation to deliver on its therapeutic possibilities. I look forward to a long and successful relationship with HollandPTC, both for the clinical parts and also for research efforts.”
HollandPTC is an independent center for proton therapy and a partnership between Erasmus University Medical Center, Leiden University Medical Center and the Delft University of Technology. In addition to patient care, the center will provide education and conduct an extensive research and development program.
RayCare* represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.
RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.
RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.
More information about RaySearch is available at www.raysearchlabs.com
* Subject to regulatory clearance in some markets.
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)8-510 530 00
Peter Thysell, CFO, RaySearch Laboratories AB (publ)
Telephone: +46 (0)70 661 05 59